Clinical and research tests for CAPN5 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 32

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
MVL Vision Panel Molecular Vision Laboratory United States	1358	1028	C Sequence analysis of the entire coding region
CAPN5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoVision Panel Centogene AG - the Rare Disease Company Germany	417	413	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Early-Onset High Myopia Panel PreventionGenetics, part of Exact Sciences United States	285	137	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Exudative vitreoretinopathy Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States	6	7	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Exudative vitreoretinopathy NGS panel HNL Genomics Connective Tissue Gene Tests United States	6	7	C Sequence analysis of the entire coding region T Targeted variant analysis
Exudative vitreoretinopathy Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States	6	7	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Vitreoretinopathy, neovascular inflammatory, 193235, Autosomal dominant; VRNI (Autosomal dominant neovascular inflammatory vitreoretinopathy) (CAPN5 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States	486	293	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Familial Exudative Vitreoretinopathy and Wagner Syndrome Amplexa Genetics Amplexa Genetics A/S Denmark	2	8	S Mutation scanning of the entire coding region
Vitreoretinopathy NGS panel HNL Genomics Connective Tissue Gene Tests United States	23	19	C Sequence analysis of the entire coding region T Targeted variant analysis
Vitreoretinopathy Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States	23	19	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Vitreoretinopathy Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States	23	19	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Exudative vitreoretinopathy NGS panel HNL Genomics Connective Tissue Gene Tests United States	6	7	C Sequence analysis of the entire coding region T Targeted variant analysis
Exudative vitreoretinopathy Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States	6	7	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Exudative vitreoretinopathy Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States	6	7	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Vitreoretinopathy, Neovascular Inflammatory via the CAPN5 Gene PreventionGenetics, part of Exact Sciences United States	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Comprehensive Vitreoretinopathy Panel PreventionGenetics, part of Exact Sciences United States	26	21	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Genomic Unity® Retinal Disorders Analysis Variantyx, Inc. United States	1	394	D Deletion/duplication analysis X Mutation scanning of select exons C Sequence analysis of the entire coding region
Retinitis Pigmentosa Panel CGC Genetics Unilabs Portugal	1	203	C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 32

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.